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Abstract
OBJECTIVES: The combination of aortic ‘no-touch’ off-pump surgery (OPCAB) and total arterial revascularization (TAR) can reduce
peri-procedural morbidity and yields excellent long-term outcomes albeit at a reported risk of incomplete revascularization. The feasi-
bility of OPCAB-TAR with speciﬁc regards to the complete revascularization (CR) in patients with multi-vessel disease was evaluated.
METHODS: From 2003 to 2010, 712 patients underwent TAR including 526 patients who had OPCAB-TAR and 186 patients who
received on-pump TAR [(ONCAB grafting (ONCABG)-TAR)]. Of these, 52% (n = 272; OPCAB) vs. 83% (n = 155; ONCABG) had triple-vessel
disease (TVD). To balance patient characteristics, a non-parsimonious, propensity score (PS) model was applied. Endpoints evaluated
were mortality, stroke, major adverse cardiac and cerebrovascular events (MACCE). To evaluate CR, an ‘Index of CR’ (ICOR) was calcu-
lated, deﬁned as the number of distal anastomoses divided by the number of the diseased coronary vessels. CR was assumed when the
following requirements were fulﬁlled: the number of distal anastomoses was equal to or higher than that of diseased vessels (ICOR ≥ 1),
and all affected coronary territories (left anterior descending, circumﬂex artery and/or right coronary artery) were grafted.
RESULTS: Mortality was comparable between groups, whereas OPCAB patients suffered from signiﬁcantly decreased rates of MACCE
[3.0 vs. 7.0%; propensity-adjusted odd ratio (PAOR) = 0.24; conﬁdence interval (CI) 95% 0.08–0.66; P = 0.006] including a clear trend
towards reduced stroke and myocardial infarction. In the subgroup with TVD, OPCAB patients presented with signiﬁcantly reduced
rates for MACCE (1.8 vs. 5.8%; PAOR = 0.07; CI 95% 0.01–0.65; P = 0.02), including a signiﬁcantly lower rate for stroke. For all-comers,
the number of diseased vessels was lower after OPCAB (2.36 ± 0.73 vs. 2.87 ± 0.39; P < 0.001) and consequently, these patients received
an overall lower number of distal anastomoses (2.42 ± 1.15 vs. 3.06 ± 0.98; P < 0.001). Although the ICOR was slightly lower (1.04 ± 0.37
vs. 1.07 ± 0.37; P = 0.02), CR was achieved more frequently in OPCAB patients (82.1 vs. 73.1%; P = 0.01). In the subgroup with TVD, the
number of distal anastomoses (2.99 ± 1.14 vs. 3.10 ± 0.98; P = 0.19) and the ICOR (1.00 ± 0.38 vs. 1.03 ± 0.33; P = 0.19) was comparable
between groups. The frequency of CR was slightly higher (75 vs. 67.7%; P = 0.11), and the proportion of complete in situ grafting was
signiﬁcantly higher after OPCAB (37.1 vs. 23.9%; P = 0.005).
CONCLUSIONS: Aortic ‘no-touch’ OPCAB-TAR leads to a signiﬁcant reduction of MACCE. It does not compromise CR in patients with
TVD and thus can be safely applied to these patients.
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INTRODUCTION
Off-pump coronary artery bypass grafting (OPCAB) offers super-
ior post-operative outcomes with regard to major cerebrovascu-
lar and cardiac complications [1–3] and disproportionally
beneﬁts high-risk patients [4]. The combination with an aortic,
no-touch strategy and/or in situ total arterial revascularization
(TAR) techniques can effectively reduce neurological complica-
tions while yielding excellent long-term outcomes [3, 5–8].
The so-called ‘aortic no-touch technique’ aims to avoid any
aortic manipulation either by using in situ arterial conduits (double
internal mammary artery and/or T- or Y-grafting) or by applying
clamp-less anastomotic devices whenever free arterial grafts have
to be used and proximal anastomoses become necessary.
Recent controlled randomized trials comparing off-pump and
on-pump CABG in low-risk patients did not show a potential
beneﬁt for off-pump surgery [9–11]. Furthermore, off-pump
surgery has been repeatedly criticized to come at a cost of less
complete revascularization (CR), suggesting that it is not prefer-
able in patients with multi-vessel disease and complex coronary
lesions [9, 11, 12].
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In this study, the safety and feasibility of combining OPCAB
and TAR with speciﬁc regard to the completeness of revasculari-
zation (CR) in patients with multi-vessel disease, excluding single
and double vessel disease was assessed.
MATERIALS AND METHODS
From 2003 to 2010, a total of 712 patients received total arterial
grafting (TAR), including 526 patients who underwent off-pump
TAR (OPCAB) and 186 patients who received on-pump TAR
[ONCAB grafting (ONCABG)]. Of these, 52% (n = 272) in the
OPCAB group vs. 83% (n = 155) in the ONCABG group suffered
from triple-vessel disease (TVD) which were also evaluated in a
separate subgroup analysis (Fig. 1). The study was approved by
an institutional review board, including a waiver of informed
consent. Tables 1 and 2 summarize demographics and preopera-
tive variables.
Surgical technique
ONCABG-TAR was carried out with standard cardiopulmonary
bypass techniques and cross-clamping of the aorta. OPCAB was
performed as previously described [3, 13]. In brief, a stabilizer
(Octopus®4 Tissue Stabilizer, Medtronic, Minneapolis, MN, USA)
was used to stabilize the heart and expose the target vessel. A
shunt (ClearView® Intracoronary Shunt, Medtronic, Minneapolis,
MN, USA) was routinely used to maintain distal perfusion.
Routine ultrasound ﬂow measurement (MediStim QuickFit®)
was done in all cases. If insufﬁcient ﬂow was documented, the
anastomosis was immediately repeated.
Revascularization strategy and aortic no-touch
techniques
Prior to surgery, all vessels with signiﬁcant lesions (>70%) were
identiﬁed in the preoperative angiography and selected as target
for revascularization. Left main coronary disease (LMD) was
deﬁned as stenosis of the left main stem >50%. Surgical revascu-
larization was started with left internal mammary artery (LIMA) to
LAD grafting, followed by the right coronary territory and ﬁnished
with the circumﬂex coronary system. In patients suffering from
LMD, the LAD and circumﬂex arteries were always grafted,
regardless of the degree of stenosis. Total arterial grafting using
in situ arterial grafts only [including T- or Y-grafting using the right
internal mammary artery (RIMA) or the radial artery (RA)] was
done whenever possible. If the RIMA and/or the RA had to be
used as free arterial grafts requiring a proximal anastomosis, a less
touch, clamp-less fashion (‘no-touch’ technique for proximal
anastomosis) using the heartstring device (HEARTSTRING™
Proximal Seal System, Guidant, Indianapolis, IN, USA) was applied
to decrease the risk for cerebral complications during clamping
and de-clamping manoeuvres. Digital palpation was done to
identify a healthy, non-calciﬁed aortic segment. Thereafter an
aortic-punch device was applied to create a circular aortotomy,
before the coiled heartstring device was inserted to create a
haemostatic seal against the aortic inner wall. The anastomosis
was carried out using a continuous 6/0 Prolene suture and before
tightening of the suture the device was removed.
Figure 1: Study cohort.
Table 1: Preoperative demographics for patients with TVD
Parameter TVD P-value
OPCAB
(n = 272)
ONCABG (n = 155)
Age (years) 64 ± 11 62 ± 9 0.01
Male (%) 80.9 85.5 0.23
EuroScore 3.7 ± 1.0 4.0 ± 1.1 0.003
EF (%) 57 ± 15 55 ± 14 0.86
Sinus rhythm (%) 95.1 98.1 0.20
Atrial fibrillation (%) 4.2 1.3 0.16
Triple-vessel disease (%) 100 100 1.00
Left main disease (%) 32.4 29.7 0.59
CCS 4 (%) 11.1 12.3 0.75
NYHA 4 (%) 1.3 3.2 0.28
EF: ejection fraction; BMI: body mass index; CCS: Canadian Cardio-
vascular Society Angina Classification; NYHA: New York Heart Association.
Table 2: Risk factors and comorbidities for patients with
TVD
Parameter TVD P-value
OPCAB
(n = 272)
ONCABG
(n = 155)
Hyperlipidaemia (%) 76.9 75.5 0.79
Hypertension (%) 48.2 61.3 0.01
Positive family History (%) 37.2 34.9 0.47
Diabetes (%) 25.7 20.6 0.28
Smoking (%) 58.6 65.6 0.19
Adipositas (%) 52.5 45.2 0.19
PAD (%) 16.0 9.7 0.08
COPD (%) 2.9 5.8 0.20
Acute MI (<90 days) (%) 15.4 20.0 0.23
Previous MI (>90 days) (%) 35.7 48.4 0.01
Cerebrovascular disease (%) 1.8 0.0 0.16
Renal disease (%) 0.7 1.9 0.62
PAD: peripheral artery disease; COPD: chronic obstructive pulmonary
disease; MI: myocardial infarction.
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Primary outcomes
To evaluate CR, an ‘Index of CR’ (ICOR) was calculated for each
individual patient [13]. The ICOR was deﬁned as the total
number of distal anastomoses performed divided by the
number of the diseased coronary vessels deﬁned on the pre-
operative coronary angiography [14]. CR was assumed when the
following two requirements were fulﬁlled: the number of distal
anastomoses was equal to or higher than that of diseased vessels
(ICOR ≥ ) and all affected coronary territories (LAD, CX and/or
RCA) were grafted.
Secondary outcomes
Major outcome endpoints were mortality, stroke and major
adverse cardiac and cerebrovascular events (MACCE) deﬁned as
composite of death, stroke and myocardial infarction (MI). In
addition, major non-cardiac adverse events such as pulmonary,
renal and bleeding complications were assessed. In patients who
required intra-operative conversion, the ‘Intention-to-treat’
methodology was applied.
Statistical analysis
The collection of data was carried out prospectively. Continuous
data are presented as mean ± SD and are compared using the
Mann–Whitney test. Categorical data are shown as numbers and
percentage, and are compared using the χ2 test and Fisher’s
exact test. Odds ratios (ORs) with 95% conﬁdence intervals (CIs)
were calculated using univariate logistic regression. A propensity
score (PS) was calculated using logistic regression and a non-
parsimonious model with numerous preoperative variables to
balance characteristics between off-pump and on-pump groups.
The c-statistic was 0.86 and 0.82 in the subgroup analysis for
patients with TVD. Missing values in preoperative variables were
replaced using multiple imputation regression methods.
Thereafter, the PS was divided into quintiles and analysed as a
categorical variable. PS-adjusted logistic regression analysis was
performed to assess binary endpoints and two-way analysis of
variance for continuous endpoints. All analyses were performed
using SPSS 18 (SPSS Inc., Chicago, IL, USA), and P < 0.05 was
assumed to be statistically signiﬁcant.
Besides size, weight, gender and body mass index, the pre-
operative variables for the non-parsimonious PS model included
patient characteristics and demographics such as cardiovascular
risk factors and comorbidities, including peripheral artery
disease (PAD), chronic obstructive pulmonary disease (COPD)
and renal disease. Cerebrovascular disease was deﬁned as a
brain dysfunction due to the known history of a transient ischae-
mic attack or stroke. Patients who presented with a medical
history of cerebrovascular disease were susceptive for it or were
of advanced age (>65 years) routinely underwent preoperative
Doppler carotid ultrasound assessment. Preoperative conditions
included were: preceding MI, MI within 3 months prior to
surgery, preceding cardiogenic-shock, congestive heart-failure,
arrhythmias, number of diseased coronary vessels, previous
CABG, elective, urgent/or emergent presentation, previous percu-
taneous coronary intervention (PCI), previous stent implantation,
New York Heart Association class, Canadian Cardiovascular
Society Angina Classiﬁcation, logistic EuroSCORE and others.
RESULTS
Patient demographics
Patient demographics and preoperative characteristics including
EuroSCORE, cardiovascular risk factors and co-morbidities are
summarized in Tables 1 and 2.
Crude outcome and propensity-adjusted analysis
for all-comers
When compared with patients who underwent the on-pump
approach, OPCAB patients suffered from signiﬁcantly decreased
rates of MACCE (3.0 vs. 7.0%; OR = 0.41; CI 95% 0.19–0.88;
P = 0.02), including a clear trend towards reduced stroke (1.0 vs.
2.7%; OR = 0.34; CI 95% 0.09–1.2; P = 0.09) and MI (1.4 vs. 2.2%;
OR = 0.63; CI 95% 0.16–2.32; P = 0.50; Table 3; Fig. 2). There were
no signiﬁcant differences with regard to non-cardiac complica-
tions and mortality was comparable for both groups (1.5 vs.
2.2%; OR = 0.70; CI 95% 0.20–2.36; P = 0.56) in the crude
Table 3: Crude outcome and propensity-adjusted outcome for all-comers
Parameter OPCAB (n = 526) ONCABG (n = 186) OR CI 95% P-value PA OR PA CI 95% PA P-value
Mortality (%) 1.5 2.2 0.70 0.20–2.36 0.56 0.16 0.03–0.78 0.02
Cerebrovascular accident (CVA) (%) 1.0 2.7 0.34 0.09–1.21 0.09 0.22 0.04–1.05 0.06
Myocardial infarction (%) 1.4 2.2 0.63 0.16–2.38 0.50 0.77 0.14–4.14 0.76
Bleeding (%) 5.5 3.8 1.49 0.64–3.42 0.35 0.76 0.28–2.30 0.66
Renal dysfunction (%) 3.4 2.7 1.28 0.46–3.50 0.62 0.78 0.23–2.61 0.69
Respiratory failure (%) 1.9 3.4 0.54 0.16–1.82 0.33 0.34 0.07–1.67 0.18
Pleural effusions/pneumothorax (%) 1.9 4.6 0.40 0.14–1.14 0.09 0.36 0.10–1.22 0.10
Sinus rhythm (%) 94.2 96.2 0.63 0.26–1.53 0.31 1.25 0.44–3.54 0.66
Atrial fibrillation (%) 4.4 3.8 1.17 0.47–2.91 0.72 0.67 0.22–1.98 0.47
MACCE (CVA/MI/mortality) (%) 3.0 7.0 0.41 0.19–0.88 0.02 0.24 0.08–0.66 0.006
OR: odds ratio; CI 95%: confidence interval 95%; PAOR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted
P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events.
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outcome, but appeared to be even signiﬁcantly lower after ad-
justment [propensity-adjusted odd ratio (PAOR) = 0.16; CI 95%
0.03–0.78; P = 0.02]. After PS adjustment, the signiﬁcant beneﬁt
for OPCAB patients with regard to the occurrence of MACCE
(PAOR = 0.24; CI 95% 0.08–0.66; P = 0.006) remained clearly
visible.
Crude outcome and propensity-adjusted analysis
for patients with TVD
In the subgroup analysis, OPCAB patients with TVD presented
with signiﬁcantly reduced rates for MACCE (1.8 vs. 5.8%;
OR = 0.30; CI 95% 0.10–0.92; P = 0.04) including a signiﬁcantly
lower rate for stroke (0.4 vs. 3.2%; OR = 0.11; CI 95% 0.01–0.95;
P = 0.04) and a lower rate for MI (0.7 vs. 1.9%; OR = 0.35; CI 95%
0.03–3.47; P = 0.37; Table 4; Fig. 3).
Following PS adjustment, MACCE was still signiﬁcantly lower
after PS adjustment (PAOR = 0.07; CI 95% 0.01–0.65; P = 0.02).
Overall mortality was comparable between both groups and did
not display any signiﬁcant differences neither before (1.5 vs.
0.6%; OR = 2.29; CI 95% 0.25–20.74; P = 0.45), nor after PS
adjustment (PAOR = 0.30; CI 95% 0.01–7.35; P = 0.46). Similarly
the overall occurrence of non-cardiac complications was
comparable between groups with a trend to reduced pulmonary
complications among OPCAB patients.
Intra-operative data and CR
In the total cohort, signiﬁcantly less OPCAB patients suffered from
TVD (51.8 vs. 83.3%; P = 0.001) and the mean number of diseased
vessels was lower among these patients when compared with the
ONCABG group (2.36 ± 0.73 vs. 2.87 ± 0.39; P < 0.001; Table 5).
Consequently, OPCAB patients received an overall lower number
of distal anastomoses (2.42 ± 1.15 vs. 3.06 ± 0.98; P < 0.001).
Although the mean ‘ICOR’ appeared to be slightly lower (1.04 ±
0.37 vs. 1.07 ± 0.37; P = 0.02) after OPCAB, CR was achieved more
frequently in these patients (82.1 vs. 73.1%; P = 0.01).
In the subgroup analysis for patients suffering from TVD, the
number of distal anastomoses (2.99 ± 1.14 vs. 3.10 ± 0.98;
P = 0.19) and the ICOR (1.00 ± 0.38 vs. 1.03 ± 0.33; P = 0.19) was
comparable between groups. The frequency of CR (75 vs. 67.7%;
P = 0.11) was higher after the OPCAB approach, but failed to
achieve statistical signiﬁcance. With regards to the type of used
grafts, ONCABG received signiﬁcantly more RIMA grafts (58.8 vs.
83.3%; P < 0.001), whereas patients who underwent OPCAB
received more radial artery grafts (66.9 vs. 50.3%; P < 0.001). The
proportion of complete in situ grafting was signiﬁcantly higher
among OPCAB patients (37.1 vs. 23.9%; P = 0.005).
The need for intra-operative placement of an IABP was lower
among OPCAB patients for all-comers (2.9 vs. 6.5%; P = 0.04) as
well as in the subgroup analysis (3.3 vs. 7.1%; P = 0.09).
DISCUSSION
This study demonstrates the feasibility and safety of aortic no
touch, total arterial off-pump surgery in patients with TVD. The
Table 4: Crude outcome and propensity-adjusted outcome for patients with TVD
Parameter TVD OR CI 95% P-value PA OR PA CI 95% PA P-value
OPCAB (n = 272) ONCABG (n = 155)
Mortality (%) 1.5 0.6 2.29 0.25–20.74 0.45 0.30 0.01–7.35 0.46
Cerebrovascular accident (CVA) (%) 0.4 3.2 0.11 0.01–0.95 0.04 n/a n/a n/a
Myocardial infarction (%) 0.7 1.9 0.35 0.03–3.47 0.37 0.30 0.02–3.94 0.36
Bleeding (%) 6.3 3.9 1.65 0.63–4.29 0.30 0.76 0.21–2.74 0.67
Renal dysfunction (%) 3.7 3.2 1.14 0.38–3.41 0.80 0.60 0.15–2.34 0.46
Respiratory failure (%) 1.1 3.9 0.27 0.03–2.30 0.23 0.22 0.02–2.09 0.19
Pleural effusions/pneumothorax (%) 0.7 5.2 0.12 0.01–1.04 0.06 0.11 0.01–0.94 0.04
Sinus rhythm (%) 95.1 95.5 0.91 0.31–2.68 0.87 1.76 0.51–6.10 0.37
Atrial fibrillation (%) 4.2 4.5 0.92 0.30–2.82 0.89 0.50 0.14–1.81 0.30
MACCE (CVA/MI/mortality) (%) 1.8 5.8 0.30 0.10–0.92 0.04 0.07 0.01–0.65 0.02
OR: odds ratio; CI 95%: confidence interval 95%; PA OR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted
P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events; n/a: not calculable (too small number of events).
Figure 2: Forrest plots with ORs and 95% CIs showing crude (a) and
propensity-adjusted outcomes (b) for all-comers.
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overall outcome data presented here conﬁrm the beneﬁcial
effect of OPCAB-TAR with regards to MACCE and, in particular,
neurological complications. Furthermore, the study highlights
that a standardized OPCAB-TAR approach does not come at
price of incomplete revascularization in patients with TVD and
complex coronary lesions.
Randomized, prospective trials comprising low-risk patients
did not show signiﬁcant differences between OPCAB and
ONCABG [9–11]. In contrast, numerous observational studies
demonstrate signiﬁcant beneﬁcial effects of OPCAB with regards
to risk-adjusted morbidity such as MACCE and neurological
complications [2–4, 6, 8, 13, 15]. The combination with aortic no
touch, total arterial grafting strategies has been demonstrated to
further decrease the risk for stroke. This may apply in particular
for ‘high-risk’ patients presenting with numerous comorbidities,
multi-vessel disease and a general high calciﬁc load due to
the presence of concomitant LMD or PAD [16]. A recent
meta-analysis of Edelman et al. has highlighted the beneﬁcial
effect of aortic no-touch techniques when compared with both,
the conventional on-pump technique and partial-clamping
approaches during off-pump or on-pump beating heart surgery
[6]. In this study, a standardized no-touch OPCAB-TAR technique
was associated with a very stroke rate for all-comers (1.0%) and
for the subgroup with TVD (0.4%). Our ﬁndings are in line with
several studies reporting a low stroke rate ranging from 0 to 1%
associated with this technique [1, 3, 5, 6, 8].
The no touch, all arterial grafting approach may be carried out
in different ways by either using double internal mammary
grafts, radial arteries or both as well as different composite graft-
ing strategies such as Y- or T-grafting depending on the degree
of coronary artery disease (one-/two-vessel disease versus TVD)
and the individual anatomy of the patient, [5, 8, 17]. The use of
in situ grafts/composites is preferable whenever possible; but in
patients with TVD, the use of free arterial grafts requiring a prox-
imal anastomosis may be preferable in certain circumstances [3,
13, 18, 19]. In this case, the proximal anastomosis can be safely
performed in a clamp-less fashion to avoid any aortic manipula-
tion yielding similar results for stroke as achieved with no touch,
all arterial grafting approach [3, 13, 18].
Another important aspect of this study was to focus on the
feasibility of CR in patients with complex coronary lesions. OPCAB
has been repeatedly criticized to be associated with incomplete
revascularization due to the technical challenge in patients pre-
senting with multi-vessel disease [11, 12, 20]. In a recent study,
evaluating 8081 consecutive patients who underwent isolated sur-
gical revascularization, Filardo et al. [12] have suggested that
OPCAB is not the appropriate strategy in patients with multi-vessel
disease and that ONCABG might be preferable as it may achieve a
more complete and durable revascularization.
In contrast to this report, this study highlights that a standar-
dized OPCAB-TAR approach is not associated with a less CR in
patients with TVD. This is clearly reﬂected by a comparable
Figure 3: Forrest plots with ORs and 95% CIs showing crude (a) and
propensity-adjusted outcomes (b) for patients with TVD; n/a, not calculable
(too small number of events).
Table 5: Intra-operative data
Parameter OPCAB, (n = 526) ONCABG, (n = 186) P-value TVD P-value
OPCAB (n = 272) ONCABG (n = 155)
CPB conversion (%) 6.5 — — 6.3 —
CPB time (min) — 95 ± 37 — — 96 ± 37 —
Aortic X-clamp time (min) — 42 ± 29 — — 43 ± 29 —
IABP intraoperative (%) 2.9 6.5 0.04 3.3 7.1 0.09
Number of diseased vessels 2.36 ± 0.73 2.87 ± 0.39 <0.001 3.00 3.00 1.00
Total number of anastomoses per patient 2.42 ± 1.15 3.06 ± 0.98 <0.001 2.99 ± 1.14 3.10 ± 0.98 0.19
Complete in situ grafting (%) 73.4 76.9 0.38 37.1 23.9 0.005
LIMA (%) 93.7 94.1 1.00 93.0 94.2 0.69
RIMA (%) 50.0 81.7 <0.001 58.8 83.2 <0.001
Radial artery (%) 44.3 50.0 0.19 66.9 50.3 <0.001
Completeness of revascularization (%) 82.1 73.1 0.01 75.0 67.7 0.11
ICOR 1.04 ± 0.37 1.09 ± 0.37 0.02 1.00 ± 0.38 1.03 ± 0.33 0.19
CPB: cardiopulmonary bypass; LIMA: left internal mammary artery; RIMA: right internal mammary artery; ICOR: index of complete revascularization; IABP:
intra aortic balloon pump.
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‘ICOR’ as well as an overall higher frequency of achieved CR in
patients who underwent OPCAB-TAR. The overall number of dis-
eased vessels was lower in the all-comers analysis for OPCAB
patients, but in the subgroup analysis for patients with TVD
(being equal in the number of diseased vessels), the ICOR
remained comparable and the frequency of CR was still slightly
higher in the OPCAB-TAR group.
One obvious reason for the reported less CR may be associated
with the principal ‘learning curve’ of surgeons relatively inexperi-
enced in the OPCAB technique [15, 21]. Currently, only 20% of
coronary bypass procedures are performed in off-pump fashion
in the Western World [12, 21, 22]. Experience in OPCAB surgery
may have an important impact on the CR [14, 23]. The feasibility
of CR in off-pump surgery has been demonstrated by several
groups considered as ‘high volume’ OPCAB centres [2, 4, 15, 21,
22]. A recent article of Patel and Angellini suggested the idea
of so-called expert centres to optimize the potential beneﬁts
of OPCAB while decreasing associated problems such as high
conversion rates and incomplete revascularization due to
inexperience and low case loads [15, 21, 22].
In summary, this report highlights the importance of no-touch
OPCAB-TAR when considering the outcomes of surgical revascu-
larization versus PCI. The higher incidence of stroke that is
brought forward as a major drawback for surgery [24] can be
compensated with this technique and has to be considered in
consecutive future trials. This may strengthen the argument for
surgical revascularization to be the most appropriate therapy in
patients with TVD.
Limitations
First, due to the retrospective, non-randomized design all estab-
lished disadvantages apply. Although, PS adjustment is a valuable
tool, it cannot equal the advantages of a prospective, rando-
mized trial representing the highest level of evidence [25]. On
the other hand, and as exemplarily seen in the ROOBY trial [11],
prospective trials may often be subject to a certain selection bias
enrolling preferably low-risk patients what may not represent the
‘real world’ in the daily clinical practice. Secondly, the study
period was long and being a surgical centre with a continuously
increasing frequency of the OPCAB technique (nowadays >95%
of OPCAB procedures), most of the on-pump procedures were
done in the earlier part of the study.
Conﬂict of interest: none declared.
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APPENDIX. CONFERENCE DISCUSSION
Dr T. Kieser (Alberta, AB, Canada): To my mind, your hospital in Zurich uses
one of the best ways to perform total arterial off-pump bypass surgery: as
much bilateral internal thoracic artery as possible, as much in situ BITA as
possible, use of the HEARTSTRING™ device for proximal anastomoses, use of
shunts to perform the distals, and the use of transit-time ﬂow intraoperatively
to assess your grafts. I have two questions.
The many endpoints and combination of endpoints are confusing. Ideally,
there is one primary objective, two or three secondary, and the rest can be
exploratory. This would cut down the number of P values and reduce the
chance of a Type 1 error. I would like to know what you would choose to be
your main primary endpoint.
Secondly, the comparison of the overall group is questionable because
there is such a difference in the percentage of patients with triple vessel
disease: 51.8% in the off-pump group and 83.3% in the on-pump. Propensity
analysis, although useful to balance groups, may not be statistically valid
when the event rates are low and/or the sample size is not large enough.
Would you agree that a sample size estimate calculation might help deter-
mine if the number of subjects in your study is sufﬁcient to include signiﬁ-
cance for the events?
Dr Emmert: Your ﬁrst question actually is a very good one. Of course, we
have included a lot of endpoints also in the full paper and I agree that this
might be a bit confusing. This was actually due to the fact that we are per-
forming a lot of subgroup analysis at the moment. Professor Taggart nicely
pointed out that off-pump should be applied to a margin of patients and es-
pecially to high-risk patients. That’s why we need to ﬁrst deﬁne what a high-
risk patient is. Is a high-risk patient a patient presenting with renal failure or
pulmonary failure, or a patient presenting with a calciﬁed aorta? That’s why
we have developed a statistical analysis tool where we put in all the different
subgroups to get a better insight into which patients beneﬁt most of from the
off-pump technique. But I agree, and that’s why I have actually only pre-
sented the cardiac-related complications in this talk. On the other hand, I
think it’s worthwhile for the interested reader that we tell them the full results
for the subgroups.
Regarding your second question, I fully agree with you, I would love to
have had 7,000 patients instead of 700 to get a higher signiﬁcance in terms
of propensity adjustment. We took advice from an expert on that and he
also mentioned, of course, that we have some limitations there; however,
we always go for the best we have and tried to perform the adjustment
wherever possible. I think propensity scoring is of great value to adapt your
study ﬁndings and to further improve the signiﬁcance. And as I mentioned,
for example, with regards to the stroke rate, this was a good example
where we were not able to go further and to perform a propensity-
adjusted analysis.
Dr Kieser: It’s just your event rates are so low, it’s hard, which is good.
A
D
U
LT
C
A
R
D
IA
C
M.Y. Emmert et al. / European Journal of Cardio-Thoracic Surgery e31
